 |
Professor
McInness studied medicine in the University of Glasgow (honours 1989).
He trained in PhD and post doctoral studies via fellowships from The
Wellcome Trust, ARC(UK) and NIH Fogarty Fellowship Programme in NIH in
Glasgow and the National Institutes of Health in Bethesda, MD.
He
is now Professor of Experimental Medicine in the University of Glasgow.
His research interests include understanding the role of cytokines in
inflammatory synovitis, both from the basic laboratory perspective of
functional activity and using a translational medicine approach whereby
such molecules also offer therapeutic utility. He leads a trials unit
specialising in the use of biologic agents in early clinical trials in
inflammatory arthritis. Recently these studies have extended to include
the role of inflammation in promoting vascular disease, particularly
atherogenesis.
His work has been recognised in receipt of the
Michael Mason Prize 2001, from the British Society for Rheumatology,
the Albrecht Hasinger Lectureship 2002, Berlin, Germany, the Dalhousie
Lectureship, Canada 2007 and in election to Fellowship of the Royal
Society of Edinburgh 2008. He served as Chairman of the EULAR
Scientific Committee from 2004-2007 and from 2009 has been elected to
chair the European Committee for Clinical Affairs (EULAR). He is vice
chair of the arc Research committee and sits on the MRC Panel for
Fellowships and Training and on the newly formed Panel for
Translational Medicine.
|